Late-stage Product Development and Approvals by Biotechnology Companies After Initial Public Offering, 1997-2016

Laura  M McNamee; Ekaterina Galkin G Cleary; Sunyi Zhang; Usama Salim; Fred Ledley

doi:1879-114X

Late-stage Product Development and Approvals by Biotechnology Companies After Initial Public Offering, 1997-2016

Laura M McNamee
, Ekaterina Galkin G Cleary
, Sunyi Zhang
, Usama Salim
, Fred Ledley

Natural and Applied Sciences

Research output: Contribution to journal › Article

Abstract

This work describes the late-stage product portfolios of the biotechnology companies that completed initial public offerings (IPOs) from 1997 to 2016. We asked whether these emerging companies continue to develop innovative, biologic products and produce the innovation promised by the early biotechnology industry.

Original language	English
Pages (from-to)	156-171.e15
Journal	Unknown journal
Volume	43
Issue number	1
DOIs	https://doi.org/1879-114X
State	Published - 2021

Access to Document

1879-114X

Cite this

@article{95d76560468b405d8f93af9b667e6ffd,

title = "Late-stage Product Development and Approvals by Biotechnology Companies After Initial Public Offering, 1997-2016",

abstract = "This work describes the late-stage product portfolios of the biotechnology companies that completed initial public offerings (IPOs) from 1997 to 2016. We asked whether these emerging companies continue to develop innovative, biologic products and produce the innovation promised by the early biotechnology industry.",

author = "McNamee, \{Laura M\} and Cleary, \{Ekaterina Galkin G\} and Sunyi Zhang and Usama Salim and Fred Ledley",

year = "2021",

doi = "1879-114X",

language = "English",

volume = "43",

pages = "156--171.e15",

journal = "Unknown journal",

number = "1",

}

TY - JOUR

T1 - Late-stage Product Development and Approvals by Biotechnology Companies After Initial Public Offering, 1997-2016

AU - McNamee, Laura M

AU - Cleary, Ekaterina Galkin G

AU - Zhang, Sunyi

AU - Salim, Usama

AU - Ledley, Fred

PY - 2021

Y1 - 2021

N2 - This work describes the late-stage product portfolios of the biotechnology companies that completed initial public offerings (IPOs) from 1997 to 2016. We asked whether these emerging companies continue to develop innovative, biologic products and produce the innovation promised by the early biotechnology industry.

AB - This work describes the late-stage product portfolios of the biotechnology companies that completed initial public offerings (IPOs) from 1997 to 2016. We asked whether these emerging companies continue to develop innovative, biologic products and produce the innovation promised by the early biotechnology industry.

U2 - 1879-114X

DO - 1879-114X

M3 - Article

VL - 43

SP - 156-171.e15

JO - Unknown journal

JF - Unknown journal

IS - 1

ER -

Late-stage Product Development and Approvals by Biotechnology Companies After Initial Public Offering, 1997-2016

Abstract

Access to Document

Fingerprint

Cite this